Liver tumor treatment study for large tumors
Part of Cancer, Digestive system clinical trials.
This study tests a targeted radiation treatment called Y90 for liver tumors that are too large for standard approaches. It aims to see how well the treatment works for people with primary or secondary liver cancers that mainly affect the liver and have at least one tumor bigger than 5 cm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years
- You have liver tumors that started in the liver or spread from elsewhere, with most of the disease in the liver
- You have at least one tumor that is larger than 5 cm
- Your remaining healthy liver is expected to be large enough (more than 40% of total liver or over 500 ml)
- You are healthy enough to have imaging tests like CT, MRI, and a special scan before and after treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests combining radiation therapy (radioembolization) with surgery to remove part of the liver for people with a single large liver tumor (over 8 cm) that hasn't spread. The goal is to see if this approach can treat the tumor effectively.
This trial tests a treatment called Y-90 radioembolization (SIRT) for people with liver cancer that is too large to be removed surgically. The treatment delivers tiny radioactive beads directly to the tumor through the liver's blood supply, which may shrink the tumor and improve outcomes.
This study tests a higher dose of radiation delivered directly to liver tumors through small beads. It aims to improve tumor control while keeping side effects manageable for people whose liver cancer is not removable by surgery.
This trial tests a treatment called yttrium-90 radioembolization (tiny radioactive beads delivered to the liver) for people with liver cancer that has already been treated before. The goal is to see if it can help control the tumor when other treatments haven't been enough.
This trial tests a treatment called radioembolization (yttrium-90) given before surgery for colorectal cancer that has spread to the liver. It aims to shrink the liver tumors so that surgery becomes safer and more effective, and it also looks at immune markers and dosimetry to personalize the treatment.
This trial tests a radiation treatment called Y-90 given before liver surgery for colorectal cancer that has spread to the liver. The goal is to help the liver grow enough for safer, curative surgery, either right away or as part of a two-step operation.
Hear when a new Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.